Page 6 - Alex Arzeno News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GBS Inc Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse

GBS Inc Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAlex arzenoTim mccarthySteven boyagesIr communicationsgbs incUniversity of east angliaArentfox schiffCompany contactCheryl billsoncomma communicationsCustomer servicesIntelligent fingerprinting limitedGbs incExchange commissionLadenburg thalmann coSecurities exchange

GBS Inc Enters into Exclusivi - GuruFocus com

GuruFocus Article or News written by GuruFocusNews and the topic is about:

United kingdomUnited statesAlex arzenoCheryl billsonTim mccarthySteven boyagesIr communicationsUniversity of east angliaLifesci advisorsArentfox schiffCompany contactCustomer servicesIntelligent fingerprinting limitedExchange commissionComma communicationsLadenburg thalmann co

GBS INC Announces Adjournment of 2022 Annual Meeting of Stockholders to July 13, 2022

GBS INC Announces Adjournment of 2022 Annual Meeting of Stockholders to July 13, 2022
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Alex arzenoTim mccarthyExchange commissionIr communicationsLifesci advisorsCompany contactInvestor relations departmentSecurities exchangeEastern timeAnnual meetingLooking statementsSecurities actSecurities exchange actPrivate securities litigation reform actBiosensor platformVice president

GBS Inc to Hold Virtual 2022 Annual Shareholder Meeting on

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for.

Alex arzenoTim mccarthyExchange commissionIr communicationsLifesci advisorsCompany contactSecurities exchangeGbs incCall detailsEastern timeAnnual meetingLooking statementsSecurities actSecurities exchange actPrivate securities litigation reform actBiosensor platform

GBS Inc Reports Third Quarter 2022 Financial Results and Recent Business Highlights

- Initiated prospective study to collect coincident samples of oral fluidand blood following IRB approval -

United statesAlex arzenoTim mccarthySteven boyagesLifesci advisorsIr communications gbs incGbs incExchange commissionBiosensor algorithm developmentDepartment of pathologySecurities exchangeQuest diagnosticsUniversity of newcastleClinical development initiated trialCash equivalentsMarketable securities